BD is deploying $1.1 million in cash and product donations to seven non-profit organizations – Direct Relief, the International Medical Corps, Americares, the World Health Organization-United Nations Foundation COVID-19 Solidarity Response Fund, Project HOPE, the CDC Foundation and the Wuhan Red Cross – to advance those organization's work to contain COVID-19, support healthcare workers and treat patients in countries throughout the world.
BD is also putting attention to the following efforts:
- Announced new products to help aid in the detection and identification of COVID-19, including a molecular test for the detection of COVID-19 for clinical laboratories in countries recognizing the CE mark.
- Partnered with BioGX to announce that the companies have submitted Emergency Use Authorization (EUA) requests to the FDA for new diagnostic tests that would increase the potential capacity to screen for COVID-19 by thousands of tests per day.
- Partnered with BioMedomics to announce the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes.
- Collaborating with peers from across the industry, HHS, FDA and private partners to identify and validate additional swab types as well as transport medium options in order to expand capacity and alternative collection methods.